comprehensive -WSS

comprehensive

author：Wikipedia 2025-10-01 00:48:42 - browse：4

A liver with a smooth and healthy left half and a bumpy, browning right half — chronic disease coverage from STAT — Adobe

Akero Therapeutics said Monday that extending treatment with its experimental drug for the liver disease known as MASH from six months to two years resulted in better outcomes for patients — most notably reductions in liver scarring at a rate three times higher than placebo without worsening other symptoms.

The mid-stage study of the Akero drug called efruxifermin achieved its main goal in September 2022. With longer treatment, more patients with MASH responded to the drug, while those who initially benefited showed durable improvements.

“We’re really pleased with the data. It’s exactly what we were hoping to see,” said Kitty Yale, Akero’s chief development officer, in an interview with STAT. “It’s not just the high response rates, but the fact that responses are sustained and broadened as well.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： Will the IRA bring competition to the biologics market?

hotspot

WSS

PEPFAR is under serious threat — and so is global health

Mass General, Mayo Clinic look to monetize custom

Walmart eyes Medicare Advantage provider ChenMed

Walmart eyes Medicare Advantage provider ChenMed

Cardiologists urge adding sexual orientation, gender identity to health records

Prior authorization reform is both possible and imperative

Wikipedia

comprehensive

entertainment

Alkermes shareholders re

Pumping milk in bathrooms at health conferences is common

Guidelines to prevent youth baseball injuries need more muscle

Mass General, Mayo Clinic look to monetize custom

Duchenne breakthrough therapy leaves behind pioneering families

Microsoft launches AI tool for clinical documentation through Epic

The cancer drug shortage isn’t new — and neither are the solutions

HPV vaccine, cervical cancer study delivers historic results

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

To bolster infectious disease surveillance, genomics powerhouses team up

Wikipedia

Diverse clinical trials: Why aren’t we there yet?

Dana Farber says 6 studies to be retracted and 31 corrected

HPV vaccine, cervical cancer study delivers historic results

A common UTI test for kids haunts adults as a traumatic 'nightmare'

Mass General, Mayo Clinic look to monetize custom

Diverse clinical trials: Why aren’t we there yet?

Wikipedia

hotspot

focus

hotspot